Home Blog Page 79

Antengene Publishes Preclinical Research Paper on CD73 Small Molecule Inhibitor ATG-037 Combined with Selinexor in Cancer Gene Therapy

By
Advertorial Desk
-

SHANGHAI and HONG KONG, Sept. 14, 2026 /PRNewswire/ — Antengene Corporation Limited  (“Antengene”, SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological malignancies indications, today announced that a preclinical research paper evaluating the combination of ATG-037 (CD73 Small Molecule Inhibitor) and selinexor for the treatment of multiple myeloma (MM), conducted in collaboration with the Department of Hematology at Peking University Third Hospital, has been published in Cancer Gene Therapy, an international SCI journal under Springer Nature.

Details of the Paper
Title: CD73 inhibitor enhances the antitumor activity of selinexor in multiple myeloma by restoring the activation of CD8+ T cells
Journal: Cancer Gene Therapy
DOI: 10.1038/s41417-026-01078-9

Study Design:

The research team first analyzed CD73 expression across multiple tumor cell lines following selinexor treatment, then tested the combination in vivo using a J558-inoculated BALB/c mouse model, with mice divided into a vehicle group, an ATG-037 monotherapy group, a selinexor monotherapy group and a combination-therapy group. Single-cell RNA sequencing was used to characterize immune cell subtypes and tumor-immune crosstalk, immunofluorescence staining was performed on tumor tissue, and a co-culture model of CD8+ T cells and multiple myeloma cell lines was established to confirm the mechanism behind the combination’s antitumor effect.

Key Findings: 

Selinexor treatment was found to upregulate CD73 expression in the majority of tumors, a resistance-associated mechanism that the combination approach was designed to counter. In the mouse model, the combination therapy suppressed tumor growth with an inhibition rate of 62%, compared with 31% for ATG-037 monotherapy and 43% for selinexor monotherapy. Single-cell RNA sequencing showed that the combination synergistically potentiated CD8+ T cell activation by enhancing the interaction between CD8+ T cells and Enpp1+ cells via the CD80–CD28 signaling pathway, and the resulting increase in CD8+ T cell infiltration into tumor tissue was confirmed by immunofluorescence staining. In co-culture experiments, CD73 inhibition was shown to strengthen selinexor-mediated tumor cell killing by activating CD8+ T cells, with significantly elevated levels of Granzyme B (P=0.0252) and IFN-γ (P=0.0067) observed in the combination group.

Conclusion:

The study highlights the synergistic potential of combining selinexor with a CD73 inhibitor for enhancing CD8+ T cell-mediated tumor cytotoxicity in MM. Selinexor therapy upregulates CD73 in the TME, driving adenosine accumulation and an immunosuppressive state. Combined use of ATG-037 blocks this immunosuppressive feedback loop via suppression of CD73-dependent adenosine synthesis, restoring CD8+ T cell activation and proliferation while enhancing T cell cytotoxicity through activation of the CD80-CD28 costimulatory axis. These findings establish a novel, clinically feasible therapeutic paradigm for addressing drug resistance and refractory MM.

About Antengene

Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) is a global, R&D-driven, commercial-stage biotech company focused on developing first-in-class/best-in-class therapeutics for diseases with significant unmet medical needs. Its pipeline spans from preclinical to commercial stages, with key investigational candidates including ATG-022 (CLDN18.2 ADC), ATG-037 (oral CD73 inhibitor), ATG-101 (PD-L1 x 4-1BB bispecific antibody), ATG-125 (B7-H3 × PD-L1 bispecific ADC), ATG-207 (αCD3-TGF-β bifunctional fusion protein), as well as T cell engager (TCE) programs developed using Antengene’s proprietary AnTenGager® platform.

AnTenGager®, is Antengene’s proprietary TCE 2.0 platform, featuring “2+1” bivalent binding for low expressing targets, steric hindrance masking, and proprietary CD3 sequences with fast on/off kinetics to minimize cytokine release syndrome (CRS) and enhance efficacy. These characteristics support the platform’s broad applicability across autoimmune diseases, solid tumors and hematological malignancies, with programs targeting CD19 x CD3 (ATG-201 for B cell-related autoimmune diseases; partnered with UCB), CDH6 x CD3 (ATG-106 for ovarian cancer and kidney cancer; partnered with K2 Therapeutics established by MPM BioImpact), ALPPL2 x CD3 (ATG-112 for gynecological tumors, digestive system malignancies, bladder cancer and NSCLC), LY6G6D x CD3 (ATG-110 for microsatellite-stable colorectal cancer), GPRC5D x CD3 (ATG-021 for multiple myeloma), LILRB4 x CD3 (ATG-102 for acute myeloid leukemia and chronic myelomonocytic leukemia) and FLT3 x CD3 (ATG-107 for acute myeloid leukemia).

To date, Antengene has obtained 34 investigational new drug (IND) approvals in the U.S. and Asia, and obtained new drug application (NDA) approvals in 10 Asia Pacific markets. Its lead commercial asset, XPOVIO® (selinexor), is approved in the Mainland of China, Taiwan China, Hong Kong China, Macau China, South Korea, Singapore, Malaysia, Thailand, Indonesia and Australia, and has been included in the national insurance schemes in five of these markets (Mainland of China, Taiwan China, Australia, South Korea and Singapore).

Forward-looking statements

The forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. In this article, statements of, or references to, our intentions or those of any of our Directors or our Company are made as of the date of this article. Any of these intentions may alter in light of future development. For a further discussion of these and other factors that could cause future results to differ materially from any forward-looking statement, please see the other risks and uncertainties described in the Company’s Annual Report for the year ended December 31, 2025, and the documents subsequently submitted to the Hong Kong Stock Exchange.

For more information, please contact:

PR / IR Contacts: 
Peter Qian
E-mail: peter.qian@antengene.com  

BD Contacts:
Ariel Guo
E-mail: ariel.guo@antengene.com 

Luang Prabang Power Donates Medical Equipment to Strengthen Provincial Hospital

By
Advertorial Desk
-
Luang Prabang Power Company donated more than LAK 800 million (USD 35,720) in medical equipment to Luang Prabang Provincial Hospital to strengthen local healthcare services. (Photo supplies)

On 6 July, Luang Prabang Power Company Limited (LPCL) donated three types of medical equipment worth more than LAK 800 million (USD 35,720) to Luang Prabang Provincial Hospital, strengthening the hospital’s medical capabilities and expanding local access to quality healthcare.

The donation includes a fetal heart rate monitor, a tonsillectomy surgical instrument set, and an immunoassay analyzer.

Luang Prabang Power Company donated more than LAK 800 million (USD 35,720) in medical equipment to Luang Prabang Provincial Hospital to strengthen local healthcare services. Luang Prabang, Laos. 06 July 2026. (Photo supplies)

LPCL, an associate company of CK Power Public Company Limited, developed the Luang Prabang Hydroelectric Power Project. Kitpoat Srasomsub, LPCL’s Deputy Managing Director – Construction, handed over the equipment on behalf of the company to Phouvana Anoulackkham, Director of Luang Prabang Provincial Hospital.

LPCL said the donation supports its broader effort to improve quality of life in local communities by strengthening the hospital’s capacity for medical examinations, diagnosis, and treatment. 

The company added that the initiative also contributes to United Nations Sustainable Development Goal 3 on good health and well-being.

Solidion Technology Announces Stock Buyback Program

By
Advertorial Desk
-

Board Authorization Reflects Confidence in Solidion’s Long-Term Strategy and Commitment to Enhancing Shareholder Value

DALLAS, Sept. 14, 2026 /PRNewswire/ — Solidion Technology, Inc. (NASDAQ: STI) (“Solidion Technology” or “the Company”), an advanced battery technology solutions provider, today announced that its Board of Directors (“the Board”) has authorized a new stock buyback program, pursuant to which the Company intended to buyback up to $1.0 Million of the Company’s outstanding common stock.

The stock buyback program became effective on September 13, 2026 and will remain in effect until (i) the date on which the full amount authorized has been repurchased, (ii) March 14, 2028 or (iii) the date on which the authorization is terminated by the Board.

The authorization reflects the Board’s confidence in Solidion’s long-term strategy and provides the Company with additional flexibility in its approach to capital allocation. Solidion believes that the buybacks may represent an attractive use of capital while supporting the Company’s broader objective of creating long-term value for stockholders. Open-market repurchases are expected to be conducted in accordance with applicable federal securities laws, as well as applicable Nasdaq requirements and state law.

“The Board’s authorization of this stock buyback program reflects our confidence in Solidion’s long-term prospects and our commitment to disciplined capital allocation,” said Jaymes Winters, Chief Executive Officer of Solidion Technology. “We believe that our technology, intellectual property and strategic position provide a strong foundation for future growth. This program gives us the flexibility to act when we believe market conditions present an attractive opportunity to invest in Solidion and enhance long-term value for our stockholders.”

About Solidion Technology, Inc.

Headquartered in Dallas, Texas with pilot production facilities in Dayton, Ohio, Solidion’s (NASDAQ: STI) core business includes manufacturing of battery materials and components, as well as development and production of next-generation batteries for energy storage systems, including UPS systems serving the artificial intelligence (AI) data center market and electric vehicles for ground, aerospace, and sea transportation. Solidion holds a portfolio of over 385 patents, covering innovations such as high-capacity, silane gas free and graphene-enabled silicon anodes, biomass-based graphite, advanced lithium-sulfur and lithium-metal technologies.

For more information, please visit www.solidiontech.com or contact Investor Relations.

Forward-Looking Statements 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Solidion Technology Inc., (NASDAQ: STI) (the “Company,” “Solidion,” “we,” “our” or “us”) desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words “forecasts” “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise, except as may be required by law.

Please follow us on:

LinkedIn: https://www.linkedin.com/company/solidion-tech
X: https://x.com/solidiontech?lang=en 

Sorbent to acquire Kenvue’s Stayfree and Carefree business in Australia and New Zealand

By
Advertorial Desk
-

MELBOURNE, Australia, Sept. 14, 2026 /PRNewswire/ — Sorbent Paper Company Pty Ltd (“Sorbent”) has signed an agreement with Kenvue’s Singaporean subsidiary to acquire its Stayfree and Carefree feminine care business in Australia and New Zealand. Following completion of the transaction, the business in New Zealand will be managed by Sorbent’s affiliate, Cottonsoft.

The acquisition marks Sorbent and Cottonsoft’s entry into the feminine hygiene category and represents a further step in their strategy to strengthen their positions in the consumer tissue category while expanding their portfolios through established consumer brands in adjacent categories.

Stayfree and Carefree are well-established feminine hygiene brands with strong consumer recognition and longstanding retail presence across Australia and New Zealand.

Following completion of the transaction, Sorbent and Cottonsoft intend to leverage their respective local market expertise, customer relationships, commercial capabilities and integrated supply chain to support the continued development of the Stayfree and Carefree businesses in Australia and New Zealand.

The transaction is subject to regulatory approval in Australia and New Zealand and other customary closing conditions, as well as the completion of the Kimberly-Clark and Kenvue transaction. Financial terms of the transaction have not been disclosed.

“We are pleased to have reached an agreement with Kenvue to add Stayfree and Carefree to our growing consumer portfolio in Australia and New Zealand. This acquisition reflects our focus on investing in established consumer brands with strong local positions and deep consumer recognition.

Stayfree and Carefree would be great additions to our heritage brands Sorbent and Handee in Australia, as well as Paseo, Cottonsoft and KiwiSoft in New Zealand. As we continue to strengthen our product offering and bring the best of the world to discerning consumers across ANZ, we will also be able to serve our customers even more closely through our expanded portfolio.”

– Nishant Grover, Co-Chair, Investments

About Stayfree and Carefree

Stayfree and Carefree are established feminine hygiene brands serving consumers across Australia and New Zealand. Their product portfolios include pantyliners, pads and tampons.

Carefree has a long history as a pioneer in the pantyliner category, while Stayfree is recognised for its range of ultra-thin pads and rapid absorption technology. Together, the brands have built strong consumer awareness and longstanding retail presence in the Australian and New Zealand feminine care markets.

About Sorbent Paper Company

Sorbent Paper Company is an Australian consumer tissue business with a heritage dating back to 1952. Sorbent manufactures (in Melbourne & Sydney) and distributes bathroom and facial tissues under the Sorbent brand, while kitchen towels are sold under the Handee brand. Sorbent Professional and Livi branded products are sold to Away From Home customers. Sorbent is focused on building trusted consumer and professional brands and serving customers across Australia through its local manufacturing, commercial and distribution capabilities.

About Cottonsoft

Cottonsoft is a New Zealand-operated and managed tissue converting company with a heritage dating back to 1986. The company manufactures and distributes tissue and hygiene products for consumers and businesses across New Zealand, with operations in Auckland and Christchurch. Cottonsoft’s consumer portfolio includes established brands such as CottonSofts, Paseo, Tuffy, EarthSmart and KiwiSoft, alongside its professional and Away From Home product offerings. The company has built longstanding relationships with customers across the New Zealand retail, wholesale and commercial markets, supported by local manufacturing and distribution capabilities.

Xayabouly African Swine Fever Outbreak Kills 5,400 Pigs, Poses No Risk to Humans

By
Thongsavanh Souvannasane
-
This photo is used for representational purpose only.

The African Swine Fever has spread across six districts of Xayabouly Province since the beginning of the outbreak in June, provincial authorities reported.

The disease has killed or forced the culling of more than 5,400 pigs and causing an estimated LAK 14.9 billion (about USD 665,000) in economic losses,

As of 13 August, the outbreak had affected at least 38 villages and hundreds of farming families. Xayabouly district has suffered the heaviest losses, followed by Thongmixay, Ngeun, Hongsa, Khob, and Phiang districts. 

The disease first emerged in Xayabouly district in June before spreading to six of the province’s 11 districts.

African Swine Fever is a severe, highly contagious viral disease that affects domestic and wild pigs and often carries a mortality rate close to 100 percent, according to the World Organisation for Animal Health. The virus, while devastating pig populations and farming economies. does not infect humans. Yet, people can spread it to pigs through contaminated clothing, equipment, food or other materials.

Authorities say illegal smuggling and unregulated movement of pork products continue to drive the outbreak’s spread. Some farmers have also secretly sold meat from dead pigs at cheap prices to avoid financial losses, a practice officials say undermines containment efforts and risks spreading the disease further.

The Prime Minister’s Office issued an urgent notice on 10 September ordering continued monitoring of pig and pork movement between provinces and districts, and a strict ban on importing pig products from abroad for the duration of the outbreak. 

Provincial and district administrations have banned the purchase, sale, and movement of pigs across Xayabouly Province and set up 19 roadside checkpoints at international border crossings, inter-district routes, and provincial boundaries to enforce the ban. Response teams have buried and disinfected infected livestock and distributed disinfectant, dewormer, insecticide, and deltamethrin to farms across the province.

Agricultural Crisis

The outbreak has struck alongside a separate agricultural crisis. 

Pest infestations, including armyworms, blast disease, and gall midges, have damaged wet-season rice fields across eight districts and dozens of villages across Xayabouly.

Local containment efforts have recovered most of the affected farmland, though officials say the combined toll on livestock and crops has placed significant strain on rural livelihoods.

Authorities have not said when they expect to bring the outbreak under control, but continue to monitor affected areas and encourage farmers to report suspected cases early.

Trina Storage and AMP-lify Sign MoU for 1 GWh of Grid-Connected Battery Storage Projects in Japan

By
Advertorial Desk
-

CHUZHOU, China, Sept. 14, 2026 /PRNewswire/ — Trina Storage, the energy storage business unit of Trinasolar, has signed a Memorandum of Understanding (MoU) with AMP-lify, a Japanese clean energy platform, to supply approximately 1 GWh of grid-connected battery energy storage system (BESS) equipment for AMP-lify’s projects. AMP-lify develops, constructs and operates grid-connected BESS, utility-scale solar, and onshore wind projects across Japan.

Representatives of Trina Storage and AMP-lify at the signing ceremony for a strategic cooperation MoU covering approximately 1 GWh of grid-connected BESS projects in Japan, held in Chuzhou, China
Representatives of Trina Storage and AMP-lify at the signing ceremony for a strategic cooperation MoU covering approximately 1 GWh of grid-connected BESS projects in Japan, held in Chuzhou, China

Under the MoU, Trina Storage will supply its Elementa 3 series BESS and provide related technical support for approximately 1 GWh of AMP-lify’s BESS projects. Trina Storage’s Japan team will support system configuration, technical consultation, delivery coordination and after-sales service.

Trina Storage’s Elementa 3 is equipped with Trina Storage in-house 587Ah high-capacity cell, providing up to 6.25 MWh per container for larger utility-scale sites. For projects affected by transport access, limited land or proximity to communities, the 1.56 MWh Elementa 3 Flex offers an approximately five-square-metre footprint, a weight of about 13 tonnes for standard-truck transport, operating noise of 65 dB or less and modular expansion.

Japan’s Seventh Strategic Energy Plan projects renewable energy at approximately 40–50% of power generation in fiscal year 2040 and calls for storage batteries to help balance renewable output. As variable renewable generation increases, developers need storage projects that combine appropriate system design with local execution and long-term support. Trina Storage’s BESS technology and Japan-based support are backed by its recognition as a BloombergNEF Tier 1 energy storage supplier for 11 consecutive quarters.

“Japan’s storage market needs projects that are technically sound and executable under local conditions. Working with Trina Storage’s technology and local support gives us a strong basis to move the projects from site evaluation through construction and into reliable operation,” said Martin Stein, Representative Director and CEO of AMP-lify.

“Japan’s storage market has distinct engineering and delivery requirements. Road weight limits and narrow site access affect transport, while mountainous terrain, limited land, community noise expectations, seismic design and coastal conditions influence system configuration. This MoU allows us to address those factors with AMP-lify from the earliest stages of development. By combining its local execution capabilities with our Elementa 3 portfolio and Japan-based technical support, we can configure each project around its site requirements while building toward the scale envisaged under this cooperation,” said Dr Leo Zhao, Head of Energy Storage, Trinasolar Asia Pacific.

Regent Hong Kong Celebrates Four Decades of Cantonese Culinary Excellence as Lai Ching Heen Preserves Its Legacy for Future Generations

By
Advertorial Desk
-

SINGAPORE – Media OutReach Newswire – 14 September 2026 – Regent Hong Kong highlights the four-decade culinary legacy of Lai Ching Heen, where Executive Chef Lau Yiu Fai and Head Chef Cheng Man Sang continue to preserve and pass on Cantonese techniques, flavour knowledge and craftsmanship to the next generation of chefs.

Part of Regent Hong Kong and its wider Dining Destination, Lai Ching Heen has built its reputation on refined Cantonese dining, consistency and culinary knowledge developed over time. Its story goes beyond accolades, with much of its character shaped by knowledge shared in the kitchen and carried forward through the longstanding collaboration between Chef Lau and Chef Cheng.

With a legacy spanning four decades, Lai Ching Heen is recognised for refined Cantonese dining, but its story goes beyond accolades. Much of its character comes from knowledge built over time and shared in the kitchen, led today by Executive Chef Lau Yiu Fai and Head Chef Cheng Man Sang. The point is not to hold the past still, but to know what is worth carrying forward.

A Living Expression of Cantonese Heritage

Cantonese cooking often looks simpler than it is. Steaming, double-boiling, roasting and wok cooking leave little room to hide; the result depends on timing, heat and restraint. Seasonality matters, but so does knowing when to step back and let the ingredient speak for itself.

That judgement is difficult to put into a recipe. It is learnt through repetition, observation and small corrections made over years.

At Lai Ching Heen, traditional Cantonese cooking techniques are part of the restaurant’s foundation, not as a fixed rulebook but as practical knowledge that is used and refined. This is how Cantonese culinary heritage stays alive in the kitchen rather than becoming something preserved only in theory.

The People Behind the Craft

Executive Chef Lau Yiu Fai has been closely associated with the hotel since 1980, building deep knowledge of Cantonese cuisine while continually evolving his cooking.

Head Chef Cheng Man Sang has worked alongside Chef Lau for more than 25 years. Their long collaboration gives Lai Ching Heen a shared understanding of taste, technique and standards that has developed over decades.

In a busy kitchen, that shared language matters. Decisions about texture, seasoning or when a dish needs one less flourish are made constantly. Over time, those decisions become instinctive and are passed through the team.

Chef Lau and Chef Cheng therefore preserve more than individual dishes. Together, they help maintain the way the kitchen approaches Cantonese cooking and ensure that its standards continue beyond one generation of chefs.

Cantonese Culinary Knowledge Across Generations

Many Cantonese skills are still learnt through watching, practising and being corrected.

Knife work can be demonstrated and a method can be explained, but heat control, timing and texture only become reliable after a cook has repeated them often enough to recognise the difference for themselves.

This is where mentorship becomes important.

At Lai Ching Heen, the restaurant’s identity does not rest with a single chef. It is reinforced by shared standards across the kitchen, so the reasoning behind a technique can travel with it.

This human exchange is central to how culinary knowledge is maintained and passed from one generation to the next.

Preserving Tradition Without Standing Still

Respecting tradition does not mean reproducing the same dishes in exactly the same way forever.

Cantonese cuisine stays relevant when its fundamentals are understood well enough to support change. Chef Lau’s approach reflects that balance, refining familiar flavours while creating new expressions from established techniques.

At Lai Ching Heen, ingredients, presentation and creative details can evolve, while the essentials remain clear: quality, seasonality, balance and precision.

That balance defines the restaurant’s approach to authentic Cantonese fine dining — contemporary in expression, while remaining recognisably Cantonese at heart.

Recognition Within Hong Kong’s Fine-Dining Landscape

Lai Ching Heen has maintained MICHELIN-star recognition for 17 consecutive years and was awarded Two Stars in the MICHELIN Guide Hong Kong & Macau 2026.

The restaurant also holds Two Diamonds in the Black Pearl Restaurant Guide 2026, alongside other recognition within Hong Kong’s dining landscape.

These accolades reflect the restaurant’s consistency, but its culinary identity remains rooted in the knowledge, standards and techniques maintained within its kitchen.

Under the leadership of Chef Lau and Chef Cheng, Lai Ching Heen continues to combine established Cantonese methods with contemporary refinement while maintaining the principles that have shaped the restaurant over four decades.

Cantonese Craftsmanship Within Regent Hong Kong

That sense of continuity also fits naturally within Regent Hong Kong’s approach to hospitality.

Through the hotel’s Regent Distinction, the experience is built around thoughtful details, a strong sense of place and moments designed to be savoured. Lai Ching Heen brings the same attention to detail to the table through precision and close attention to how each ingredient is handled.

The jade-inspired dining room, conceived as a jewellery box revealing Cantonese culinary treasures, provides a setting that reflects the restaurant’s cultural identity and connection to Cantonese culinary traditions.

Within Regent Hong Kong, Lai Ching Heen represents both continuity and evolution: a restaurant shaped by decades of knowledge while continuing to develop for future generations.

A Cantonese Legacy That Continues to Evolve

At Regent Hong Kong, the story of Lai Ching Heen is ultimately about people and the craft they choose to carry forward.

Chef Lau, Chef Cheng and the team around them demonstrate how a restaurant can respect its history without becoming fixed in it.

The techniques remain precise, the flavours remain recognisably Cantonese, and younger chefs learn not only what to do, but why it matters.

Through that continued transfer of knowledge, Lai Ching Heen remains a living expression of Cantonese culinary heritage within Regent Hong Kong.

Hashtag: #RegentHongKong

The issuer is solely responsible for the content of this announcement.

About Regent Hong Kong

is an iconic luxury hotel situated on Kowloon’s Victoria Harbour waterfront at 18 Salisbury Road.

Following the most extensive transformation in its history, the hotel returned to its Regent heritage with interiors by Hong Kong-born designer Chi Wing Lo. Its 497 guestrooms and suites are complemented by panoramic harbour views and a collection of dining destinations including Lai Ching Heen, The Steak House, Harbourside, The Lobby Lounge, Nobu Hong Kong and Qura Bar.

Regent Hong Kong builds on a hospitality legacy dating to its original Regent era from 1980 to 2001 while introducing a contemporary interpretation of the brand for today’s guests.

For further information, visit.

Award-Winning WRITERS AT WORK Refines Signature Writing Programme for 2027 to Develop Future-Ready Thinkers

By
Advertorial Desk
-

The refined Primary Writing Programme strengthens WRITERS AT WORK’s proprietary STORYBANKING® method to help students think independently, sustain focus and tackle increasingly complex questions with confidence.

SINGAPORE – Media OutReach Newswire – 14 September 2026 – WRITERS AT WORK, a Singapore English writing and enrichment provider recognised on the SME500 Singapore 2025 list, will introduce updates to its Primary Writing Programme, formerly the Pure Composition Writing Programme, across its seven centres in Singapore from 2 January 2027, as part of a wider curriculum refresh designed to help students sustain focused, independent thinking in an increasingly fast-paced learning environment.

Award Winning Writers At Work Refines Signature Writing Programme for 2027 To Develop Future-Ready Thinkers

Built for How Students Think Today

WRITERS AT WORK updates its curriculum annually in response to shifts in Singapore’s English examination and education landscape. The 2027 update also responds to how students today process language, sustain focus, and construct ideas, shaped by their environment, technology, and culture. As attention spans shorten in a faster, more visually driven world, the ability to sit with a difficult question and think it through has become more valuable. The renamed Primary Writing Programme reflects this shift, still anchored in composition instruction but built around how students actually develop writing competency today.

Three Updates to the Primary Writing Programme

Three updates anchor the programme. Under Flexible Writing Practice, students complete guided or independent compositions depending on lesson objectives, with the STORYBANKING® method recalibrated to sharpen critical thinking through adjusted pacing and difficulty. This gradual release of support, from guided modelling to independent application, meets students at different levels of readiness: those who need more guidance receive clearer structure, while more confident writers are pushed to transfer their learning independently and make more sophisticated writing choices.

The update also responds to a reality of how students learn today: with model compositions and ready-made phrases widely accessible, that accessibility is not itself the concern. The risk is students learning techniques without learning to think. Primary Writing Programme lessons are designed to keep that thinking process intact and complete within the lesson, so students build the ability to reason through difficult questions themselves, rather than simply recall a technique.

Selected modules also integrate bite-sized situational writing, oral, and listening comprehension practice alongside composition, giving students regular, low-stakes exposure to other examination components while reinforcing skills they have already built. The STORYBANKING® programme has also been expanded with material tied to current experiences and trends, building on rather than replacing existing content.

A Refresh for the Comprehensive English Programme

The Comprehensive English Programme, covering Primary and Secondary levels, is also being updated, with a focus on strengthening students’ ability to analyse questions and organise ideas. Existing scaffolding within the programme is being broken down further to make the thinking process more visible and explicit to students.

“The updates are not a departure from what has worked. They are a deliberate response to how our students engage with the world today,” said Jemmies Siew, Managing Director and Curriculum Director at WRITERS AT WORK. “Our aim is for students to leave each lesson still knowing how to think through a hard question themselves, not just recall a technique.”

Hashtag: #WritersAtWork #EnglishTuitioninSingapore



The issuer is solely responsible for the content of this announcement.

Writers At Work

is a Singapore English writing and enrichment provider founded in 2012. Its curriculum is built around a structured, results-oriented approach and a proprietary methodology called STORYBANKING®, and has expanded to include writing, comprehension, and oral communication instruction for Primary and Secondary levels across seven centres in Singapore. The company was recognised on the SME500 Singapore 2025 list and has a 14-year track record of students achieving full marks in composition and oral examinations.

1...787980...6,594Page 79 of 6,594